{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:30:45Z","timestamp":1717461045358},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,9,21]],"date-time":"2014-09-21T00:00:00Z","timestamp":1411257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s12072-014-9569-x","type":"journal-article","created":{"date-parts":[[2014,9,20]],"date-time":"2014-09-20T07:39:13Z","timestamp":1411198753000},"page":"373-377","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure"],"prefix":"10.1007","volume":"9","author":[{"given":"Man-Fung","family":"Yuen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,21]]},"reference":[{"key":"9569_CR1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1440-1746.2011.06971.x","volume":"27","author":"WK Seto","year":"2012","unstructured":"Seto WK, Lai CL, Yuen MF. Acute-on-chronic liver failure in chronic hepatitis B. J Gastroenterol Hepatol 2012;27:662\u2013669","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"9569_CR2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/liv.12081","volume":"33","author":"A Jindal","year":"2013","unstructured":"Jindal A, Kumar M, Sarin SK. Management of acute hepatitis B and reactivation of hepatitis B. Liver Int 2013;33(Suppl 1):164\u2013175","journal-title":"Liver Int"},{"key":"9569_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"SK Sarin","year":"2009","unstructured":"Sarin SK, Kumar A, Almeida JA. Acute-on-chronic liver failure: consensus recommendtions of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009;3:269\u2013282","journal-title":"Hepatol Int"},{"key":"9569_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-8278(88)80475-6","volume":"7","author":"C Vickers","year":"1988","unstructured":"Vickers C, Neuberger J, Buckels J, McMaster P, Elias E. Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol 1988;7:143\u2013150","journal-title":"J Hepatol"},{"key":"9569_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1440-1746.1991.tb01458.x","volume":"6","author":"Y Takahashi","year":"1991","unstructured":"Takahashi Y, Shimizu M. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentre study. The Study Group of Fulminant Hepatitis. J Gastroenterol Hepatol 1991;6:159\u2013164","journal-title":"J Gastroenterol Hepatol"},{"key":"9569_CR6","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1046\/j.1365-2036.2001.01107.x","volume":"15","author":"SW Tsang","year":"2001","unstructured":"Tsang SW, Chan HL, Leung NW, et al. Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection. Aliment Pharmacol Ther 2001;15:1737\u20131744","journal-title":"Aliment Pharmacol Ther"},{"key":"9569_CR7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2893.2002.00385.x","volume":"9","author":"HL Chan","year":"2002","unstructured":"Chan HL, Tsang SW, Hui Y, Leung NW, Chan FK, Sung JJ. The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice. J Viral Hepat 2002;9:424\u2013428","journal-title":"J Viral Hepat"},{"key":"9569_CR8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1440-1746.2004.03534.x","volume":"20","author":"A Tsubota","year":"2005","unstructured":"Tsubota A, Arase Y, Suzuki Y, et al. Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 2005;20:426\u2013432","journal-title":"J Gastroenterol Hepatol"},{"key":"9569_CR9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1086\/374226","volume":"36","author":"MF Yuen","year":"2003","unstructured":"Yuen MF, Sablon E, Hui CK, et al. Prognostic factors in severe exacerbation of chronic hepatitis B. Clin Infect Dis 2003;36:979\u2013984","journal-title":"Clin Infect Dis"},{"key":"9569_CR10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0168-8278(02)00419-1","volume":"38","author":"RN Chien","year":"2003","unstructured":"Chien RN, Lin CH, Liaw YF. The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B. J Hepatol 2003;38:322\u2013327","journal-title":"J Hepatol"},{"key":"9569_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000080877","volume":"47","author":"A Tsubota","year":"2004","unstructured":"Tsubota A, Arase Y, Suzuki Y, et al. Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infection. Intervirology 2004;47:335\u2013341","journal-title":"Intervirology"},{"key":"9569_CR12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1440-1746.2009.06089.x","volume":"25","author":"LJ Sun","year":"2010","unstructured":"Sun LJ, Yu JW, Zhao YH, Kang P, Li SC. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure. J Gastroenterol Hepatol 2010;25:583\u2013590","journal-title":"J Gastroenterol Hepatol"},{"key":"9569_CR13","first-page":"261","volume":"8","author":"J Chen","year":"2009","unstructured":"Chen J, Han JH, Liu C, et al. Short-term entecavir therapy of chronic severe hepatitis B. Hepatobiliary Pancreat Dis Int 2009;8:261\u2013266","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"9569_CR14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12072-012-9344-9","volume":"6","author":"K Ma","year":"2012","unstructured":"Ma K, Guo W, Han M, et al. Entecavir treatment prevents disease progression in hepatitis B virus-related acute-on-chronic liver failure: establishment of a novel logistical regression model. Hepatol Int 2012;6:735\u2013743","journal-title":"Hepatol Int"},{"key":"9569_CR15","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.24109","volume":"53","author":"H Garg","year":"2011","unstructured":"Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology 2011;53:774\u2013780","journal-title":"Hepatology"},{"key":"9569_CR16","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s10620-010-1257-7","volume":"55","author":"YL Cui","year":"2010","unstructured":"Cui YL, Yan F, Wang YB, et al. Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure. Dig Dis Sci 2010;55:2373\u20132380","journal-title":"Dig Dis Sci"},{"key":"9569_CR17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10238-011-0160-7","volume":"12","author":"T Chen","year":"2012","unstructured":"Chen T, He Y, Liu X, et al. Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Clin Exp Med 2012;12:159\u2013164","journal-title":"Clin Exp Med"},{"key":"9569_CR18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1499-3872(13)60025-9","volume":"12","author":"J Lai","year":"2013","unstructured":"Lai J, Yan Y, Mai L, Zheng YB, Gan WQ, Ke WM. Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure. Hepatobiliary Pancreat Dis Int 2013;12:154\u2013159","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"9569_CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhep.2010.06.043","volume":"54","author":"VW Wong","year":"2011","unstructured":"Wong VW, Wong GL, Yiu KK, et al. Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B. J Hepatol 2011;54:236\u2013242","journal-title":"J Hepatol"},{"key":"9569_CR20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jhep.2014.02.013","volume":"60","author":"CH Chen","year":"2014","unstructured":"Chen CH, Lin CL, Hu TH, et al. Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation. J Hepatol 2014;60:1127\u20131134","journal-title":"J Hepatol"},{"key":"9569_CR21","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.3748\/wjg.v20.i16.4745","volume":"20","author":"WJG Zhang","year":"2014","unstructured":"Zhang WJG, Zhang Y, Hu XY, et al. Entecavir vs lamivudine therapy for na\u00efve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. World J Gastroenterol 2014;20:4745\u20134752","journal-title":"World J Gastroenterol"},{"key":"9569_CR22","first-page":"364","volume":"12","author":"S Yu","year":"2013","unstructured":"Yu S, Jianqin H, Wei W, et al. The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis. Ann Hepatol 2013;12:364\u2013372","journal-title":"Ann Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-014-9569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-014-9569-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-014-9569-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:37:17Z","timestamp":1559446637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-014-9569-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,21]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["9569"],"URL":"https:\/\/doi.org\/10.1007\/s12072-014-9569-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,21]]}}}